Fourteen-year company veteran Richard Lapthorne will step down as Amersham chairman of the board May 7. Donald Brydon, who has been a nonexecutive director of Amersham for six years and is chair of the company's audit committee, will succeed him.
Fourteen-year company veteran Richard Lapthorne will step down as Amersham chairman of the board May 7. Donald Brydon, who has been a nonexecutive director of Amersham for six years and is chair of the company's audit committee, will succeed him. Lapthorne joined the Amersham board as a nonexecutive director in 1988. He served four years as chairman.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.